Last reviewed · How we verify
fluzone by sanofi pasteur
At a glance
| Generic name | fluzone by sanofi pasteur |
|---|---|
| Sponsor | Vanderbilt University |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
- Pain at the injection site
- Redness at the injection site
- Muscle aches
- Swelling at the injection site
- Fatigue
- Irritability
- Headache
- Drowsiness
- Axillary fever
- Loss of appetite
- Upper respiratory tract infection
- Pyrexia
Key clinical trials
- Impact of FLU Vaccination on Nasal Resident Memory Immune Responses and Peripheral Respiratory-tropic Memory Immune Responses (PHASE4)
- Durability of Vaccine Responses (PHASE4)
- Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP (PHASE3)
- Safety and Immunogenicity of GPO Seasonal Tetravalent Inactivated Split Virion Influenza Vaccine in Healthy Thais (PHASE1, PHASE2)
- Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP (PHASE4)
- Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza (PHASE4)
- Safety and Immunogenicity of the Butantan Institute Influenza Vaccine Compared to Sanofi Pasteur Influenza Vaccine (PHASE4)
- Immunogenicity of Twice-annual Influenza Vaccination in Older Adults in Hong Kong (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- fluzone by sanofi pasteur CI brief — competitive landscape report
- fluzone by sanofi pasteur updates RSS · CI watch RSS
- Vanderbilt University portfolio CI